$-0.15
(Market cap
$21 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-49.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-10.2
-
Face value
--
-
Shares outstanding
3,043,297
6 Years Aggregate
CFO
$-52.54 Mln
EBITDA
$-64.66 Mln
Net Profit
$-71.33 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Longeveron LLC (LGVN)
| 33.4 | -3.8 | -12.6 | -18.5 | -71.1 | -54.5 | -- |
|
BSE Sensex*
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Longeveron LLC (LGVN)
| -70.8 | -87.1 | -57.8 | -73.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Longeveron LLC (LGVN)
|
6.8 | 21.4 | 1.2 | -23.5 | -1,466.0 | -292 | -- | 2.1 |
| 82.7 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 71.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.9 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 107.7 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 363.8 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 538.7 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 583.2 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 353.4 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 146.5 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Longeveron LLC (LGVN)
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell... formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida. Read more
-
Co-Founder, Chief Science Officer & Chairman
Dr. Joshua Michael Hare FACC, M.D.
-
Co-Founder, Chief Science Officer & Chairman
Dr. Joshua Michael Hare FACC, M.D.
-
Headquarters
Miami, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Longeveron LLC (LGVN)
What is the current share price of Longeveron LLC (LGVN) Today?
The share price of Longeveron LLC (LGVN) is $6.75 (NASDAQ) as of 01-Sep-2026 16:00 EDT. Longeveron LLC (LGVN) has given a return of -71.15% in the last 3 years.
What is the current PB & PE ratio of Longeveron LLC (LGVN)?
Since, TTM earnings of Longeveron LLC (LGVN) is negative, P/E ratio is not available.
The P/B ratio of Longeveron LLC (LGVN) is 2.08 times as on 28-Aug-2026, a 60 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.05 |
0.20 |
2024 |
-1.61 |
1.18 |
2023 |
-0.15 |
0.47 |
2022 |
-0.36 |
0.33 |
2021 |
-1.42 |
0.65 |
What is the 52 Week High and Low of Longeveron LLC (LGVN)?
The 52-week high and low of Longeveron LLC (LGVN) are Rs 12.30 and Rs 4.75 as of 02-Sep-2026.
What is the market cap of Longeveron LLC (LGVN)?
Longeveron LLC (LGVN) has a market capitalisation of $ 21 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Longeveron LLC (LGVN)?
Before investing in Longeveron LLC (LGVN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.